From patient to patent and back - create value in the patent portfolio through the different phases of drug development

The protection of intellectual property is the cornerstone in the development of new medicines. Throughout clinical development, discoveries emerge that can often be protected in various ways, such as patent protection, SPC, regulatory protection, and data protection. How can you work strategically and integrate clinical studies and IP protection?